Skip to main content

Peer Review reports

From: Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vsobservation with predefined second-line treatment after cisplatin–gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study

Original Submission
1 Nov 2013 Submitted Original manuscript
10 Nov 2013 Author responded Author comments - Isabelle Borget
Resubmission - Version 2
10 Nov 2013 Submitted Manuscript version 2
30 May 2014 Reviewed Reviewer Report - Robert Klein
18 Jul 2014 Reviewed Reviewer Report - lucio trodella
14 Sep 2014 Author responded Author comments - Isabelle Borget
Resubmission - Version 3
14 Sep 2014 Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
8 Oct 2014 Reviewed Reviewer Report - Robert Klein
3 Nov 2014 Reviewed Reviewer Report - lucio trodella
23 Nov 2014 Author responded Author comments - Isabelle Borget
Resubmission - Version 5
23 Nov 2014 Submitted Manuscript version 5
Publishing
27 Nov 2014 Editorially accepted
15 Dec 2014 Article published 10.1186/1471-2407-14-953

You can find further information about peer review here.

Back to article page